Increased psychological symptom burden in patients with pancreatic cancer: A population-based cohort study-Reference-Cited by-同舟云学术

Increased psychological symptom burden in patients with pancreatic cancer: A population-based cohort study

Published:2020-04 Issue:3 Volume:20 Page:511-521
ISSN:1424-3903
Container-title:Pancreatology
language:en
Short-container-title:Pancreatology

Author:

Dengsø Kristine Elberg^ORCID,Andersen Elisabeth Wreford,Thomsen Thordis,Hansen Carsten Palnæs,Christensen Bo Marcel,Hillingsø Jens,Dalton Susanne Oksbjerg

Funder

Novo Nordisk Foundation

Copenhagen University Hospital Rigshospitalet

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference40 articles.

1. Global trends in pancreatic cancer mortality from 1980 through 2013 and predictions for 2017;Lucas;Clin Gastroenterol Hepatol,2016

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J Clin,2018

3. Depression and cancer mortality: a meta-analysis;Pinquart;Psychol Med,2010

4. Survival after early-stage breast cancer of women previously treated for depression: a nationwide Danish cohort study;Suppli;J Clin Oncol,2017

5. Anxiety, depression and quality of life in people with pancreatic cancer and their carers;Janda;Pancreatology,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Have a vital end-user been overlooked? Developing a shared decision intervention for patients with potential pancreatic cancer regarding the choice of surgery;PEC Innovation;2024-12

2. Predictors of Psychiatric Complications in Patients with Pancreatic Cancer: A Retrospective Cohort Study;Actas Españolas de Psiquiatría;2024-08-05

3. Exploring the Nexus of Inflammation, Depression and Pancreatic Cancer Through Machine Learning (Preprint);2024-07-17

4. Pancreatic cancer progression and mortality predicted by depression and anxiety: a systematic review and meta-analysis protocol;Frontiers in Psychiatry;2024-01-11

5. Peak Risk of Recurrence Occurs during the First Two Years after a Pancreatectomy in Patients Receiving Neoadjuvant FOLFIRINOX;Cancers;2023-10-26